Analysts Turn Bullish on Energy, Pharma, Gaming

Wall Street upgraded ConocoPhillips on Monday. The consensus moved higher, with the average analyst target rising to $143.33. The energy giant carries a $141bn market cap and remains lightly shorted at 1.6% of free float.

AbbVie got a notable target price lift from Evercore ISI. The pharma firm's target jumped to $260 from $246. That is a $14 increase on a $435bn market cap stock. AbbVie holds a strong buy-dominated consensus with 23 buy ratings versus just one sell.

DA Davidson initiated Take-Two Interactive with a Buy and a $300 price target. The gaming company behind the long-awaited GTA VI is valued at $46bn. Short interest sits at 4.2% of free float. The initiation signals growing optimism ahead of a busy release schedule.

Warner Bros. Discovery and Zoetis saw target prices trimmed. WBD's average target slipped to $29.50. Zoetis fell to $101.94. Both stocks face cautious sentiment from analysts.

Vertex Pharmaceuticals bucked that trend. Its target rose to $561.96. The biotech holds 23 buy ratings with a near-unanimous bullish outlook.